Cargando…
In‐depth proteomics reveals the characteristic developmental profiles of early lung adenocarcinoma with epidermal growth factor receptor mutation
INTRODUCTION: Lung adenocarcinoma progresses stepwise from atypical adenomatous hyperplasia to adenocarcinoma in situ (AIS), followed by minimally invasive adenocarcinoma (MIA), and then obvious invasive adenocarcinoma. In this study, we examined the protein expression profiles of early and epiderma...
Autores principales: | Dai, Tomoko, Adachi, Jun, Dai, Yuichi, Nakano, Noriyuki, Yamato, Mariko, Kikuchi, Shinji, Usui, Shingo, Minami, Yuko, Tomonaga, Takeshi, Noguchi, Masayuki, Matsubara, Daisuke, Sakamoto, Noriaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225231/ https://www.ncbi.nlm.nih.gov/pubmed/37004157 http://dx.doi.org/10.1002/cam4.5766 |
Ejemplares similares
-
ECT2 promotes lung adenocarcinoma progression through extracellular matrix dynamics and focal adhesion signaling
por: Kosibaty, Zeinab, et al.
Publicado: (2020) -
Dimethylarginine dimethylaminohydrolase 2 promotes tumor angiogenesis in lung adenocarcinoma
por: Shiozawa, Toshihiro, et al.
Publicado: (2015) -
DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma
por: Husni, Ryan Edbert, et al.
Publicado: (2019) -
ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma
por: Murata, Yoshihiko, et al.
Publicado: (2014) -
Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics
por: Shiromizu, Takashi, et al.
Publicado: (2017)